Prof. Dr. med. Christophe Valmaggia
Leiter der Abteilung für Retinologie
Augenklinik · Dept. III
The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?
Henrich P, Valmaggia C, Lang C, Cattin P. The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?. Graefes Arch Clin Exp Ophthalmol 2013
08.09.2013The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?
08.09.2013Graefes Arch Clin Exp Ophthalmol 2013
Henrich Paul B, Valmaggia Christophe, Lang Corina, Cattin Philippe C
[Treatment of serous macular detachment where optic disc pit is present--two cases]
Hermans C, Valmaggia C. [Treatment of serous macular detachment where optic disc pit is present--two cases]. Klin Monbl Augenheilkd 2013; 230:432-3.
29.04.2013[Treatment of serous macular detachment where optic disc pit is present--two cases]
29.04.2013Klin Monbl Augenheilkd 2013; 230:432-3
Hermans C, Valmaggia Christophe
[Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions]
Niederhauser N, Valmaggia C. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions]. Klin Monbl Augenheilkd 2013; 230:405-8.
29.04.2013[Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions]
29.04.2013Klin Monbl Augenheilkd 2013; 230:405-8
Niederhauser N, Valmaggia Christophe
[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease]
Brunner M, Haueter I, Valmaggia C. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease]. Klin Monbl Augenheilkd 2013; 230:396-400.
29.04.2013[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease]
29.04.2013Klin Monbl Augenheilkd 2013; 230:396-400
Brunner M, Haueter I, Valmaggia Christophe
Contrast recognizability during brilliant blue G - and heavier-than-water brilliant blue G-assisted chromovitrectomy: a quantitative analysis
Henrich P, Valmaggia C, Lang C, Priglinger S, Haritoglou C, Strauss R, Cattin P. Contrast recognizability during brilliant blue G - and heavier-than-water brilliant blue G-assisted chromovitrectomy: a quantitative analysis. Acta Ophthalmol 2012; 91:e120-4.
20.11.2012Contrast recognizability during brilliant blue G - and heavier-than-water brilliant blue G-assisted chromovitrectomy: a quantitative analysis
20.11.2012Acta Ophthalmol 2012; 91:e120-4
Henrich Paul B, Valmaggia Christophe, Lang Corina, Priglinger Siegfried G, Haritoglou Christos, Strauss Rupert W, Cattin Philippe C
[Heavy tamponade in complicated inferior retinal detachment]
Brunner M, Lang C, Valmaggia C. [Heavy tamponade in complicated inferior retinal detachment]. Klin Monbl Augenheilkd 2012; 229:407-10.
11.04.2012[Heavy tamponade in complicated inferior retinal detachment]
11.04.2012Klin Monbl Augenheilkd 2012; 229:407-10
Brunner M, Lang Corina, Valmaggia Christophe
New guidelines in the treatment of persistent central serous chorioretinopathy: PDT with half-dose verteporfin
Böni C, Kloos P, Valmaggia C, Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. New guidelines in the treatment of persistent central serous chorioretinopathy: PDT with half-dose verteporfin. Klin Monbl Augenheilkd 2012; 229:327-30.
11.04.2012New guidelines in the treatment of persistent central serous chorioretinopathy: PDT with half-dose verteporfin
11.04.2012Klin Monbl Augenheilkd 2012; 229:327-30
Böni C, Kloos Patrik, Valmaggia Christophe, Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
Photodynamic therapy in the treatment of persistent central serous chorioretinopathy: a two-year follow-up
Valmaggia C, Haueter I, Niederberger H. Photodynamic therapy in the treatment of persistent central serous chorioretinopathy: a two-year follow-up. Klin Monbl Augenheilkd 2012; 229:323-6.
02.03.2012Photodynamic therapy in the treatment of persistent central serous chorioretinopathy: a two-year follow-up
02.03.2012Klin Monbl Augenheilkd 2012; 229:323-6
Valmaggia Christophe, Haueter Ilze, Niederberger Hugo
Role of the OCT in the diagnosis of acute zonal occult outer retinopathy
Valmaggia C, Török B. Role of the OCT in the diagnosis of acute zonal occult outer retinopathy. Klin Monbl Augenheilkd 2011; 228:360-1.
11.04.2011Role of the OCT in the diagnosis of acute zonal occult outer retinopathy
11.04.2011Klin Monbl Augenheilkd 2011; 228:360-1
Valmaggia Christophe, Török Béla
[Photodynamic therapy in "Secondary Sick RPE Syndrome" after repeated intravitreal injections of VEGF inhibitors in patients with wet age-related macular degeneration]
Kloos P, Niederberger H, Valmaggia C. [Photodynamic therapy in "Secondary Sick RPE Syndrome" after repeated intravitreal injections of VEGF inhibitors in patients with wet age-related macular degeneration]. Klin Monbl Augenheilkd 2011; 228:340-4.
11.04.2011[Photodynamic therapy in "Secondary Sick RPE Syndrome" after repeated intravitreal injections of VEGF inhibitors in patients with wet age-related macular degeneration]
11.04.2011Klin Monbl Augenheilkd 2011; 228:340-4
Kloos Patrik, Niederberger Hugo, Valmaggia Christophe
Intraocular haemorrhages in von Willebrand's disease
Valmaggia C, Korte W. Intraocular haemorrhages in von Willebrand's disease. Klin Monbl Augenheilkd 2010; 227:345-6.
20.04.2010Intraocular haemorrhages in von Willebrand's disease
20.04.2010Klin Monbl Augenheilkd 2010; 227:345-6
Valmaggia Christophe, Korte W
[Subretinal silicone oil and perfluorocarbon in a patient with an optic disc pit]
Prahs P, Valmaggia C, Helbig H. [Subretinal silicone oil and perfluorocarbon in a patient with an optic disc pit]. Klin Monbl Augenheilkd 2010; 227:191-3.
16.03.2010[Subretinal silicone oil and perfluorocarbon in a patient with an optic disc pit]
16.03.2010Klin Monbl Augenheilkd 2010; 227:191-3
Prahs P M, Valmaggia Christophe, Helbig H
Spontaneous closure of a traumatic macular hole
Valmaggia C, Pfenninger L, Haueter I. Spontaneous closure of a traumatic macular hole. Klinische Monatsblätter für Augenheilkunde 2009; 226:361-2.
01.04.2009Spontaneous closure of a traumatic macular hole
01.04.2009Klinische Monatsblätter für Augenheilkunde 2009; 226:361-2
Valmaggia Christophe, Pfenninger L, Haueter Ilze
The treatment of choroidal neovascularizations in age-related macular degeneration using either Avastin or Lucentis
Valmaggia C, Haueter I, Kloos P, Lang C, Niederberger H. The treatment of choroidal neovascularizations in age-related macular degeneration using either Avastin or Lucentis. Klinische Monatsblätter für Augenheilkunde 2009; 226:294-8.
01.04.2009The treatment of choroidal neovascularizations in age-related macular degeneration using either Avastin or Lucentis
01.04.2009Klinische Monatsblätter für Augenheilkunde 2009; 226:294-8
Valmaggia Christophe, Haueter Ilze, Kloos Patrik, Lang C, Niederberger Hugo
Microplasmin: ex vivo characterization of its activity in porcine vitreous
de Smet M, Valmaggia C, Zarranz-Ventura J, Willekens B. Microplasmin: ex vivo characterization of its activity in porcine vitreous. Investigative ophthalmology & visual science 2009; 50:814-9.
01.02.2009Microplasmin: ex vivo characterization of its activity in porcine vitreous
01.02.2009Investigative ophthalmology & visual science 2009; 50:814-9
de Smet Marc D, Valmaggia Christophe, Zarranz-Ventura Javier, Willekens Ben
The treatment of choroidal neovascularisation with intravitreal injections of bevacizumab (Avastin)
Valmaggia C, Niederberger H, Lang C, Kloos P, Haueter I. The treatment of choroidal neovascularisation with intravitreal injections of bevacizumab (Avastin). Klinische Monatsblätter für Augenheilkunde 2008; 225:380-4.
01.05.2008The treatment of choroidal neovascularisation with intravitreal injections of bevacizumab (Avastin)
01.05.2008Klinische Monatsblätter für Augenheilkunde 2008; 225:380-4
Valmaggia Christophe, Niederberger Hugo, Lang C, Kloos Patrik, Haueter Ilze
[Uveitis-quiz 2007]
Bischoff P, Rüesch R, Valmaggia C. [Uveitis-quiz 2007]. Klinische Monatsblätter für Augenheilkunde 2008; 225:332-5.
01.05.2008[Uveitis-quiz 2007]
01.05.2008Klinische Monatsblätter für Augenheilkunde 2008; 225:332-5
Bischoff Peter, Rüesch Reinhard, Valmaggia Christophe
Uveal effusion syndrome
Valmaggia C, Helbig H, Fretz C. Uveal effusion syndrome. Klinische Monatsblätter für Augenheilkunde 2007; 224:317-9.
01.04.2007Uveal effusion syndrome
01.04.2007Klinische Monatsblätter für Augenheilkunde 2007; 224:317-9
Valmaggia Christophe, Helbig H, Fretz C
Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes
Valmaggia C. Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes. Klinische Monatsblätter für Augenheilkunde 2007; 224:292-6.
01.04.2007Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes
01.04.2007Klinische Monatsblätter für Augenheilkunde 2007; 224:292-6
Valmaggia Christophe
[Visual improvement of an amblyopic eye in an adult patient after visual loss in the non-amblyopic eye]
Lengyel D, Valmaggia C. [Visual improvement of an amblyopic eye in an adult patient after visual loss in the non-amblyopic eye]. Klinische Monatsblätter für Augenheilkunde 2006; 223:462-4.
01.05.2006[Visual improvement of an amblyopic eye in an adult patient after visual loss in the non-amblyopic eye]
01.05.2006Klinische Monatsblätter für Augenheilkunde 2006; 223:462-4
Lengyel D, Valmaggia Christophe